146 related articles for article (PubMed ID: 18502691)
1. Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Clin Immunol; 2008 Aug; 128(2):199-204. PubMed ID: 18502691
[TBL] [Abstract][Full Text] [Related]
2. Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Hum Immunol; 2008 Mar; 69(3):179-86. PubMed ID: 18396210
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
[TBL] [Abstract][Full Text] [Related]
5. CRP genetic polymorphism is associated with lymph node metastasis in thoracic esophageal squamous cell cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Saito H; Minamiya Y; Satoh S; Murata K; Suzuki T; Ogawa J
Ann Surg Oncol; 2009 Sep; 16(9):2479-85. PubMed ID: 19495883
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
[TBL] [Abstract][Full Text] [Related]
7. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China.
Liu R; Yin LH; Pu YP
Chin Med J (Engl); 2007 Oct; 120(20):1797-802. PubMed ID: 18028774
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes coding for mediators in the interleukin cascade and their effect on susceptibility to sarcoidosis in the Slovenian population.
Maver A; Medica I; Salobir B; Sabovic M; Tercelj M; Peterlin B
Int J Mol Med; 2007 Sep; 20(3):385-90. PubMed ID: 17671745
[TBL] [Abstract][Full Text] [Related]
10. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing.
Giacconi R; Cipriano C; Albanese F; Boccoli G; Saba V; Olivieri F; Franceschi C; Mocchegiani E
Exp Gerontol; 2004 Apr; 39(4):621-8. PubMed ID: 15050298
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
13. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer.
Shimizu Y; Kondo S; Shirai A; Furukawa M; Yoshizaki T
Auris Nasus Larynx; 2008 Sep; 35(3):381-9. PubMed ID: 18276095
[TBL] [Abstract][Full Text] [Related]
14. Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking.
Wang H; Liu Y; Tan W; Zhang Y; Zhao N; Jiang Y; Lin C; Hao B; Zhao D; Qian J; Lu D; Jin L; Wei Q; Lin D; He F
Cancer Sci; 2008 Apr; 99(4):787-91. PubMed ID: 18294291
[TBL] [Abstract][Full Text] [Related]
15. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study.
Aulisa L; Papaleo P; Pola E; Angelini F; Aulisa AG; Tamburrelli FC; Pola P; Logroscino CA
Spine (Phila Pa 1976); 2007 Nov; 32(24):2700-2. PubMed ID: 18007247
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women.
Bhanoori M; Babu KA; Deenadayal M; Kennedy S; Shivaji S
J Soc Gynecol Investig; 2005 Jul; 12(5):365-9. PubMed ID: 15979549
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-18 -607A/C polymorphism is not associated with risk for oral cancer.
Vairaktaris E; Serefoglou ZC; Yapijakis C; Agapi C; Vassiliou S; Nkenke E; Antonis V; Sofia S; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(6B):4011-4. PubMed ID: 18225563
[TBL] [Abstract][Full Text] [Related]
19. [Serum level and genotype of interleukin-6 in patients with esophageal cancer].
Tang RG; Wei YS; Chen HM; Fang WZ; Long XK; Yuan XH
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1126-8. PubMed ID: 17672997
[TBL] [Abstract][Full Text] [Related]
20. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis].
Wu XB; Dai LP; Wang YP; Wang KJ; Zhang JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):281-5. PubMed ID: 19642387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
